ICON Public Limited Company (NASDAQ: ICLR) is highlighted in Seth Klarman’s investment portfolio due to its low price-to-earnings multiple. Mizuho raised its price target on ICLR from $173 to $225 with an ‘Outperform’ rating, citing strong operational metrics and stable quarterly booking trends. The company’s improved cancellation rates and reduced trial delays have boosted investor confidence.

Analysts see enhanced earnings visibility for 2026 for ICLR, despite market uncertainties. The price revision reflects short-term momentum and long-term strategic positioning, increasing the company’s potential to capture a larger share of clinical trial demand. ICLR offers outsourced development and commercialization services globally and is considered a cheap value stock.

While ICLR shows investment potential, some AI stocks offer higher upside with less downside risk. Investors seeking undervalued AI stocks can explore opportunities in the market. For more insights, check out the best short-term AI stock recommendations. Additional information on AI stocks and top stock picks is also available for reference. No disclosures related to this news article.

Read more at Yahoo Finance: Mizuho Raises PT on ICON Public Limited Company (ICLR) to $225; Maintains ‘Outperform’ Rating